Diagnostic effectiveness of TSH screening and of T4 with secondary TSH screening for newborn congenital hypothyroidism

Clinica Chimica Acta

Volumn 274, Issue 2, 1998, Pages 151-158

  Wang, Stephen T ^a   Pizzolato, Sam ^a   Demshar, Helen P ^a  

^a ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

Congenital hypothyroidism (CH); Newborn screening; Receiver operating characteristic (ROC) plot

Indexed keywords

THYROTROPIN; THYROXINE;

ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL;

CONGENITAL HYPOTHYROIDISM; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; NEONATAL SCREENING; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; THYROTROPIN; THYROXINE;

EID: 0032557881     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00057-6     Document Type: Article

References (17)

1. [1] Dussault JH, Coulombe P, Laberge C, Letarte J, Gayda H, Khoury K. Preliminary report on a mass screening programme for neonatal hypothyroidism. J Pediatr 1975;86:670-4.
2. [2] American Academy of Pediatrics Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993;91:1203-9.
3. [3] Toublanc JE, Rochiccioli P, Torresani T, et al. Epidemiological inquiry on congenital hypothyroidism in Europe, (1985-1988). Horm Res 1990;34:1-3.
4. [4] Wang ST, Pizzolato S, Demshar HP. Receiver operating characteristic curve of Wallac DELFIA neonatal thyrotropin system for newborn congenital hypothyroidism. In: Glass M, editor. Proceedings of the 10th National Neonatal Screening Symposium, Seattle, WA, June 7-11, 1994:245-6.
5. [5] Foley TP, Torresani TE. Congenital hypothyroidism. In: Pass KA, Levy HL, editors. Early hospital discharge: impact on newborn screening. Atlanta, GA: CORN, 1995:133-154.
6. [6] Dussault JH, Morissette J. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: a myth?. J Clin Endocrinol Metab 1983;56:849-52.
7. [7] Tuerck JM, Miyahira R, Skeels M, Rien L, Sesser D, Buist NRM. Newborn screening strategies: routine second tests - Oregon. In: Pass KA, Levy HL, editors. Early hospital discharge: impact on newborn screening. Atlanta, GA: CORN, 1995:201-212.
8. [8] Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
9. [9] Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
10. [10] Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993;30:521-39.
11. [11] Shultz EK. Multivariate receiver operating characteristic curve analysis: prostate cancer screening as an example. Clin Chem 1995;41:1248-55.
12. [12] Wang ST, Demshar HP. Screening for neonatal hypothyroidism with the Pharmacia DELFIA TSH kit: four incubation protocols compared. Screening 1993;2:165-71.
13. [13] DELFIA neonatal thyroxine (T4) kit. Time resolved fluoroimmunoassay kit A065-110. Wallac, March 1995.
14. [14] Metz programs. Charles E. Metz, Department of Radiology, MC2026, The University of Chicago Medical Center, 5841 South Maryland Ave., Chicago, IL 60637-1470; Internet c-metz@u-chicago.edu.
15. [15] Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curve derived from the same cases. Radiology 1983;148:839-43.
16. [16] Therrell BL. Second testing in newborn screening program in the US. In: Pass KA, Levy HL, editors. Early hospital discharge: impact on newborn screening. Atlanta, GA: CORN, 1995:75-86.
17. [17] Baumgartner JH. Screening for primary hypothyroidism in Missouri, using a thyroxine and TSH assay for all specimens: a five-year experience. In: Therrell BL, Aldis BG, editors. Proceedings of the 11th National Neonatal Screening Symposium, Corpus Christi, TX, September 12-16, 1995:39-42.